Nurx is a telemedicine company offering a safe and easy solution for getting birth control and HIV prevention medication prescribed and delivered to your door. Their direct-to-consumer platform allows for the patient to provide his or her personal clinical information to a physician, allowing the physician to review their file and then prescribe or consult with the patient in an asynchronized care setting. As an end-to-end platform, Nurx then directly delivers the medications, leading to an overall experience that is more convenient, consumer-friendly, cost-effective, and price transparent.
Launched in 2015, Nurx has caught the nation’s attention and is now available in 17 states and Washington, D.C. Nurx is led by Co-Founders Hans Gangeskar and Dr. Edvard Engesæth, and is backed by YCombinator, Union Square Ventures, and Kleiner Perkins. With their rapid growth and top tier backers, Nurx is positioned to scale nationally and expand their portfolio of products to transform the healthcare industry with their mission of giving its patients full control of their health.